Kosei Kimura

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 3

Top Topics

Metastatic Breast Cancer

Epidermal Growth Factor Receptor

Top Venues

British journal of clinical pharmacology

Cancer chemotherapy and pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Emi Goto, Takeo Hata, Masami Nishihara, Masashi Neo, Mitsuhiko Iwamoto, Kosei Kimura, Masahiro Goto, Yoshiyuki Rikitake
Preventive effect of dexamethasone premedication on the development of infusion-related reaction in breast cancer patients receiving trastuzumab. British journal of clinical pharmacology (2023)
Emi Goto, Takeo Hata, Masami Nishihara, Masashi Neo, Mitsuhiko Iwamoto, Kosei Kimura, Masahiro Goto, Yoshiyuki Rikitake
Preventive effects of dexamethasone premedication on the development of infusion-related reactions in breast cancer patients receiving trastuzumab. British journal of clinical pharmacology (2023)
Kosei Kimura, Mitsuhiko Iwamoto, Satoru Tanaka, Daigo Yamamoto, Katsuhide Yoshidome, Hiroyuki Ogura, Risa Terasawa, Nobuki Matsunami, Yuko Takahashi, Toshikatsu Nitta, Takashi Morimoto, Hiroya Fujioka, Kanako Kawaguchi, Kazuhisa Uchiyama
A phase II, multicenter, single-arm trial of eribulin as first- or second-line chemotherapy for HER2-negative advanced or metastatic breast cancer: evaluation of efficacy, safety, and patient-reported outcomes. Cancer chemotherapy and pharmacology 81 (5) (2018)